USFDA
-
Franchise India Bureau Mar 01 2018 - 1 min readDrug firm Zydus Cadila has confirmed to have received the final approval from US health regulator FDA to market Dexmedetomidine Hydrochloride injection used for sedation of patients under intensive care. Zydus Cadila in a regulatory filing said the approval from USFDA is to market Dexmedetomidine Hydrochloride injection 200 mcg (base)/ 2 ...
-
Franchise India Bureau Dec 22 2017 - 1 min readZydus Pharmaceuticals (USA) Inc has received final approval from the US health regulator to market Nifedipine extended release tablets used in treatment of hypertension and chest pain. The company has received the approval from the US Food and Drug Administration (USFDA) to market the drug in the strengths of 30mg, 60mg and 90 mg, Zydus ...
-
WI Bureau Sep 29 2017 - 2 min readPharma major Zydus Cadila has received a tentative nod from the US health regulator USFDA to market Glipizide tablets used for the treatment of diabetes in the US.